124
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Establishment and Validation of a Predictive Model for Post-Treatment Anxiety Based on Patient Attributes and Pre-Treatment Anxiety Scores

, , , &
Pages 3883-3894 | Received 08 Jun 2023, Accepted 08 Sep 2023, Published online: 19 Sep 2023

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19–28. doi:10.1002/1099-1611(200101/02)10:1<19::aid-pon501>3.0.co;2-6
  • An Y, Fu G, Yuan G. Quality of Life in Patients With Breast Cancer: the Influence of Family Caregiver’s Burden and the Mediation of Patient’s Anxiety and Depression. J Nerv Ment Dis. 2019;207(11):921–926. doi:10.1097/NMD.0000000000001040
  • Grusdat NP, Stäuber A, Tolkmitt M, et al. Routine cancer treatments and their impact on physical function, symptoms of cancer-related fatigue, anxiety, and depression. Support Care Cancer. 2022;30(5):3733–3744. doi:10.1007/s00520-021-06787-5
  • Härtl K, Engel J, Herschbach P, Reinecker H, Sommer H, Friese K. Personality traits and psychosocial stress: quality of life over 2 years following breast cancer diagnosis and psychological impact factors. Psychooncology. 2010;19(2):160–169. doi:10.1002/pon.1536
  • Hashemi SM, Rafiemanesh H, Aghamohammadi T, et al. Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis. Breast Cancer. 2020;27(2):166–178. doi:10.1007/s12282-019-01031-9
  • Wang X, Wang N, Zhong L, et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Mol Psychiatry. 2020;25(12):3186–3197. doi:10.1038/s41380-020-00865-6
  • Gold M, Dunn LB, Phoenix B, et al. Co-occurrence of anxiety and depressive symptoms following breast cancer surgery and its impact on quality of life. Eur J Oncol Nurs. 2016;20:97–105. doi:10.1016/j.ejon.2015.06.003
  • Xie X, Li H, Wang C, et al. Effect of modified radical mastectomy combined with neo-adjuvant chemotherapy on postoperative recurrence rate, negative emotion, and life quality of patients with breast cancer. Am J Transl Res. 2022;14(1):460–467.
  • He X, Ng MSN, Choi KC, So WKW. Effects of a 16-week dance intervention on the symptom cluster of fatigue-sleep disturbance-depression and quality of life among patients with breast cancer undergoing adjuvant chemotherapy: a randomized controlled trial. Int J Nurs Stud. 2022;133:104317. doi:10.1016/j.ijnurstu.2022.104317
  • Kim YH, Choi KS, Han K, Kim HW. A psychological intervention programme for patients with breast cancer under chemotherapy and at a high risk of depression: a randomised clinical trial. J Clin Nurs. 2018;27(3–4):572–581. doi:10.1111/jocn.13910
  • Izci F, Ilgün AS, Fındıklı E, Özmen V. Psychiatric Symptoms and Psychosocial Problems in Patients with Breast Cancer. J Breast Health. 2016;12(3):94–101. doi:10.5152/tjbh.2016.3041
  • Pilevarzadeh M, Amirshahi M, Afsargharehbagh R, Rafiemanesh H, Hashemi SM, Balouchi A. Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis. Breast Cancer Res Treat. 2019;176(3):519–533. doi:10.1007/s10549-019-05271-3
  • Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40(11):1797–1810. doi:10.1017/S0033291709992285
  • Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115(22):5349–5361. doi:10.1002/cncr.24561
  • Shim EJ, Lee JW, Cho J, et al. Association of depression and anxiety disorder with the risk of mortality in breast cancer: a National Health Insurance Service study in Korea. Breast Cancer Res Treat. 2020;179(2):491–498. doi:10.1007/s10549-019-05479-3
  • Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat. 2007;105(2):209–219. doi:10.1007/s10549-006-9447-x
  • Salam A, Woodman A, Chu A, et al. Effect of post-diagnosis exercise on depression symptoms, physical functioning and mortality in breast cancer survivors: a systematic review and meta-analysis of randomized control trials. Cancer Epidemiol. 2022;77:102111. doi:10.1016/j.canep.2022.102111
  • Al-Alawi KS, Al-Azri M, Al-Fahdi A, Chan MF. Effect of Psycho-Educational Intervention to Reduce Anxiety and Depression at Postintervention and Follow-Up in Women with Breast Cancer: a Systematic Review and Meta-Analysis. Semin Oncol Nurs. 2022;38(6):151315. doi:10.1016/j.soncn.2022.151315
  • Yu S, Li W, Tang L, et al. Depression in breast cancer patients: immunopathogenesis and immunotherapy. Cancer Lett. 2022;536:215648. doi:10.1016/j.canlet.2022.215648
  • Pepe MS, Fan J, Feng Z, Gerds T, Hilden J. The Net Reclassification Index (NRI): a Misleading Measure of Prediction Improvement Even with Independent Test Data Sets. Stat Biosci. 2015;7(2):282–295. doi:10.1007/s12561-014-9118-0
  • Soqia J, Al-Shafie M, Agha LY, et al. Depression, anxiety and related factors among Syrian breast cancer patients: a cross-sectional study. BMC Psychiatry. 2022;22(1):796. doi:10.1186/s12888-022-04469-y
  • Dihge L, Bendahl PO, Rydén L. Nomograms for preoperative prediction of axillary nodal status in breast cancer. Br J Surg. 2017;104(11):1494–1505. doi:10.1002/bjs.10583
  • Park SY. Nomogram: an analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg. 2018;155(4):1793. doi:10.1016/j.jtcvs.2017.12.107